A detailed history of Td Asset Management Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 123,118 shares of ACLX stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
123,118
Previous 89,918 36.92%
Holding current value
$10.2 Million
Previous $6.25 Million 8.65%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$49.74 - $66.98 $1.65 Million - $2.22 Million
33,200 Added 36.92%
123,118 $6.79 Million
Q1 2024

May 08, 2024

BUY
$51.85 - $73.49 $445,910 - $632,014
8,600 Added 10.58%
89,918 $6.25 Million
Q4 2023

Feb 12, 2024

SELL
$31.75 - $57.99 $8,953 - $16,353
-282 Reduced 0.35%
81,318 $4.51 Million
Q3 2023

Oct 27, 2023

BUY
$31.51 - $37.4 $1.66 Million - $1.97 Million
52,800 Added 183.33%
81,600 $2.93 Million
Q2 2023

Aug 09, 2023

BUY
$27.49 - $46.9 $791,712 - $1.35 Million
28,800 New
28,800 $910,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.63B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.